In line with our observation, in a murine model of rheumatoid arthritis, treatment of mice with IM7.8.1 anti-CD44 antibody was accompanied by a significant increase in serum CD44 level compared to baseline level (Day 0) (39). This evidence concerns the gene CD44 and rheumatoid arthritis.